Monitoring circulating tumor DNA levels before and during treatment may predict melanoma recurrence, offering a potential ...

Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify ...

Regular workouts are essential for a healthier, longer life, reducing the risk of major illnesses and early death.

Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

Researchers showed that approximately 80 percent of stage 3 melanoma patients who had detectable levels of circulating tumor ...

Key Players to WatchDublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & ...

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...

AIIMS Delhi has developed a blood test using ddPCR tech to detect HPV DNA for early cervical cancer detection, relapse ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.